Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study
Open Access
- 20 November 2020
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 109 (5), 1341-1348
- https://doi.org/10.1016/j.ijrobp.2020.11.040
Abstract
No abstract availableFunding Information
- British Lung Foundation
- Cancer Research UK
This publication has 36 references indexed in Scilit:
- How can we optimise concurrent chemoradiotherapy for inoperable stage III non-small cell lung cancer?Lung Cancer, 2014
- Dose-Limiting Toxicity After Hypofractionated Dose-Escalated Radiotherapy in Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2013
- Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancerEuropean Journal of Cancer, 2012
- Hyperfractionated or Accelerated Radiotherapy in Lung Cancer: An Individual Patient Data Meta-AnalysisJournal of Clinical Oncology, 2012
- Defining Local-Regional Control and Its Importance in Locally Advanced Non-small Cell Lung CarcinomaJournal of Thoracic Oncology, 2012
- Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2010
- Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based studyAnnals of Oncology, 2009
- CT-based definition of thoracic lymph node stations: An atlas from the University of MichiganInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patientsLung Cancer, 1999
- Radiotherapy Alone Versus Combined Chemotherapy and Radiotherapy in Nonresectable Non-Small-Cell Lung Cancer: First Analysis of a Randomized Trial in 353 PatientsJNCI Journal of the National Cancer Institute, 1991